Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
type: MedicalStudy
description: Multicentric Randomized Phase 2. Immunotherapy With CpG-ODN in Malignant Glioblastoma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-09
end date: 2010-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00190424
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Assistance Publique - Hôpitaux de Paris
study subject: Glioblastoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Glioblastoma

AI Analytics
type: Organization